Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2024-10-22 00:00:00 ET · period of report 2024-10-18 · accession 0001714899-24-000206 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-22 | 2024-10-18 | DNLI | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $0.68 | +40.0K | 275.8K | +17% | +$27.2K |
| D | 2024-10-22 | 2024-10-18 | DNLI | Watts Ryan J. | Pres, CEO, Dir | S - Sale+OE | $27.69 | -40.0K | 235.8K | -15% | -$1.11M |
| D | 2024-10-22 | 2024-10-18 | DNLI | Watts Ryan J. | Pres, CEO, Dir | M - OptEx | $0.00 | -40.0K | 1.08M | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-18 | M | A | 40,000 | $0.68 | 275,807 | D | — | — | (F1) Includes 197,200 Unvested RSUs. |
| 2 | Common | Common Stock | 2024-10-18 | S | D | 40,000 | $27.69 | 235,807 | D | — | — | (F3) The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $27.49 to $28.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. (F1) Includes 197,200 Unvested RSUs. |
| 3 | Derivative | Stock Option (right to buy) | 2024-10-18 | M | D | 40,000 | $0.00 | 1,078,091 | D | $0.68 · — to 2025-08-20 | 40,000 Common Stock | (F5) The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days. |